Neurocrine Biosciences to Present at Deutsche Bank Securities 27th Annual Health Care 2002 Conference
SAN DIEGO, May 7 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will be presenting at the Deutsche Bank Securities 27th Annual Health Care 2002 Conference held in Baltimore today, Tuesday, May 7, 2002 at 3:30PM Eastern Daylight Time (12:30PM Pacific Daylight Time). The presentation will be simultaneously webcast and can be viewed through a link provided via the Company's website at http://www.neurocrine.com
Gary Lyons, President and CEO of Neurocrine will discuss the Company's insomnia program as well as highlighting the Company's pipeline. Viewers are encouraged to visit the website approximately 15 minutes prior to the presentation to download or install any necessary audio software. If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 658-7600 and ask for Claudia Jones. The presentation will be archived for 30 days.
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, malignant brain tumors and peripheral cancers, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, stroke, and certain female health disorders.
Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com .
MAKE YOUR OPINION COUNT - Click Here
http://tbutton.prnewswire.com/prn/11690X46139114
SOURCE Neurocrine Biosciences, Inc.
Web site: http: //www.neurocrine.com
CONTACT: Claudia Jones, or Paul Hawran, both of Neurocrine Biosciences, +1-858-658-7600